Clinicopathologic characteristics of T-cell non-Hodgkin's lymphoma: A single institution experience

Korean Journal of Internal Medicine

Volumn 24, Issue 2, 2009, Pages 128-134

  Ock, Bae Ko ^a   Dae, Ho Lee ^a   Sang, We Kim ^a   Jung, Shin Lee ^a   Kim, Shin ^a   Huh, Jooryung ^a   Suh, Cheolwon ^a,b  

^a University of Ulsan College of Medicine   (South Korea)

^b Asan Medical Center   (South Korea)

Author keywords

Lymphoma; Peripheral; T cell

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HUMAN; KOREA; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; NK T CELL LYMPHOMA; NONHODGKIN LYMPHOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PATHOLOGY; PERIPHERAL T CELL LYMPHOMA; PROGNOSIS; RETROSPECTIVE STUDY; SCORING SYSTEM; SURVIVAL; T CELL LYMPHOMA; T CELL NONHODGKIN LYMPHOMA; TUMOR CLASSIFICATION; TUMOR LOCALIZATION; TUMOR VOLUME; ASIAN; ETHNOLOGY; INCIDENCE; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; PREDICTION AND FORECASTING; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; TIME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; INCIDENCE; KAPLAN-MEIERS ESTIMATE; KOREA; LYMPHOMA, NON-HODGKIN; LYMPHOMA, T-CELL; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; TIME FACTORS; YOUNG ADULT;

EID: 67650747442     PISSN: 12263303     EISSN: None     Source Type: Journal    
DOI: 10.3904/kjim.2009.24.2.128     Document Type: Article

References (32)

1. American Cancer Society. Cancer facts and figures [Internet]. Cited 2008. Available from: www.cancer.org.
2. Muller A, Ihorst G, Mertelsmann R, Engelhardt M. Epidemiology of non-Hodgkin's lymphoma (NHL): trends, geographic distribution, and etiology. Ann Hematol 2005;84:1-12. (Pubitemid 39625035)
3. IARC. Cancer incidence, mortality and prevalence worldwide, version 1.0 IARC Cancer Base N0.5 [Internet]. Cited 2001. Available from: http://www-dep.iarc.fr/globocan.htm.
4. The international Non-Hodgkin's Lymphoma Prognostic Factors Project. A predictvie model for aggressive non-Hodgkin's lymphoma. N Engl J Med 1993;329:987-994.
5. Ko YJ, Kim CW, Park CS, et al. Classification of malignant lymphomas in the Republic of Korea: incidence of recently recognized entities and changes in clinicopathologic features. Hematolymphoreticular Study Group of the Korean Society of Pathologists. Revised European-American lymphoma. Cancer 1998;83:806-812.
6. Mok TS, Steinberg J, Chan AT, et al. Application of the international prognostic index in a study of Chinese patients with non-Hodgkin's lymphoma and a high incidence of primary extranodal lymphoma. Cancer 1998;82:2439-2448. (Pubitemid 28283452)
7. Jaffe ES, Chan JK, Su IJ, et al. Report of the Workshop on Nasal and Related Extranodal Angiocentric T/Natural Killer Cell Lymphomas: definitions, differential diagnosis, and epidemiology. Am J Srug Pathol 1996;20:103-111. (Pubitemid 3024135)
8. The Non-Hodgkin's Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. Blood 1997;89:3909-3918.
9. Rudiger T, Weisenbruger DD, Anderson JR, et al. Peripheral T-cell lymphoma (excluding anaplastic large cell lymphoma): results from the Non-Hodgkin's Lymphoma Classification Project. Ann Oncol 2002;13:140-149. (Pubitemid 34436738)
10. Kim HT, Im YH, Suh CI, et al. Malignant lymphomas in Korea. J Korean Cancer Assoc 1992;24:92-101.
11. Lopez-Guillermo A, Colomo L, jimenez M, et al. Diffuse lagrge B-cell lymphoma: clinical and biological characterization and outcome according to the nodal and extranodal primary origin. J Clin Oncol 2005;23:2797-2804. (Pubitemid 46179470)
12. Harris NL, Jaffe ES, Diebold J, et al. The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clincal Advisory Committee Meeting, Airlie House, Virginia, November 1997. Histopathology 2000;36:69-86. (Pubitemid 30055426)
13. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53.
14. Mantel N. Evaluation of survival data and two new rank test order statistics arising in tis consideration. Cancer Chemother Rep 1966;50:163-170.
15. Cox D. Regression models and life-tables. J R Stat Soc 1972;34.
16. Rizvi MA, Evens AM, Tallman MS, Nelsoon BP, Rosen ST. T-cell non-Hodgkin lymphoma. Blood 2006;107:1255-1264.
17. Kadin ME, Berard CW, Nanba K, Wakasa H. Lymphoproliferative diseases in Japan and Western countries: proceedings of the United States-Japan Seminar, September 6 and 7, 1982, in Seattle, Washington. Hum Pathol 1983;14:745-772.
18. Ho FC, Todd D, Loke SL, Ng RP, Khoo RK. Clinico-pathological features of malignant lymphomas in 294 Hong Kong Chinese patients: retrospective study covering an eight-year period. Int J Cancer 1984;34:143-148. (Pubitemid 14053133)
19. The T- and B-cell Malignancy Group. Statistical analyses of clinico-pathological, virological and epidemiological data on lymphoid malignancies with special reference to adutl T-cell leukemia/lymphoma: a report of the second nationwide study of Japan. Jpn J Clin Oncol 1985;15:517-535.
20. The Nationwide Lymphoma Pathology Cooperative Group (NLPCG). A retrospective histological study of 9,009 cases of malignant lymphoma in China using the NLPCG classification. Jpn J Clin Oncol 1985;15:645-651.
21. Aozasa K, Tsujimoto M, Sakurai M, et al. Non-Hodgkin's lymphomas in Osaka, Japan. Eur J Cancer Clin Oncol 1985;21:487-492.
22. Newton R, Ferlay J, Beral V, Devesa S. The epidemiology of non-Hodgkin's lymphoma: comparison of nodal and extranodal sites. Int J Cancer 1997;72:923-930. (Pubitemid 27433552)
23. Anderson JR, Armitage JO, Weisenbruger DD. Epidemiology of the non-Hodgkin's lymphomas: distrubtions of the major subtypes differ by geographic locations. Non-Hodgkin's Lymphoma Classification Project. Ann Oncol 1998;9:717-720.
24. National Cancer Center, National Cancer Registry of Korea [internet]. National Cancer center c2008. cited 2008 Oct 1. Available from: http://www.ncc.re.kr
25. Kang YK, Kim BS, Kim TW, et al. Clinicopathologic characteristics of Korean non-Hodgkin's lymphomas based on REAL classification. J Korean Cancer Assoc 1999;31:641-652.
26. Falini B, Pileri S, Zinzani PL, et al. ALK+ lymphoma: clinocopathologcial findings and outcome. Blood 1999;93:2697-2706. (Pubitemid 29181203)
27. Gascoyne RD, Aoun P, chhanabhai M, et al. Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma. Blood 1999;93:3913-3921.
28. Gospodarowicz MK, Sutcliffe SB. The extranodal lymphomas. Semi Radiat Oncol 1995;5:281-300.
29. Zucca E, Roggero E, Bertoni F, Cavalli F. Primary extranodal non-Hodgkin's lymphomas: part I. gastrointestinal, cutaneous and genitourinary lymphomas. Ann Oncol 1997;8:727-737.
30. Zucca E, Conconi A, Cavalli F. Treatment of extranodal lymphomas. Best pract Res Clin Haematol 2002;15:533-547.
31. Shih LY, Liang DC. Non-Hodgkin's lymphomas in Asia. Hematol Oncol Clin North Am 1991;5:983-1001.
32. Greiner TC, Medeiros LJ, Jaffe ES. Non-Hodgkin's lymphoma. Cancer 1995;75(1 Suppl):370-380.